Good (non-COVID) medical news
DNA tests aren't just for heredity and risk factors now. A blood sample can yield a zillion fragments of damaged DNA bases with reliable signatures for many types of very early--treatable--cancer. The WSJ is behind a paywall, but this Google link takes you to an article entitled "Cancer Screening Leaps Forward."
Subscribe to:
Post Comments (Atom)
1 comment:
The money is going to be in medical, because companies will pay for that research. Just so you know, the Chinese are already a little ahead of us in this, because they have control over so many genomes. That advantage is about to expand. They have more than double the population of Europe plus US, and five times the privacy-invading enforcement. Researchers will assure you how much a 10x increase in N improves your ability to detect rare variants, over and above your certainty to locate small common factors.
Post a Comment